Selling into a wave of new capacity being built by others: management describes its customers' own build-out spending as
The model's full reasoning — Q3 2016 call → NOWe need to determine if management explains current momentum and near-term trajectory by pointing to a wave of new building/equipping/capacity-creation by other parties, for which the company already supplies part, and that this build-out is early/intensifying. The transcript is about Fate Therapeutics, a biotech developing cell therapies. The company's programs: ProTmune (hematopoietic cell graft), FATE-NK100 (NK cell therapy), ToleraCyte, iPSC-derived NK/T cells. The call discusses clinical trials, IND filings, partnerships. Key points: They are advancing their own clinical programs. They mention opening clinical sites, amending protocols, IND filings. They talk about partnerships with Memorial Sloan-Kettering, Juno. They discuss their own manufacturing and development. Is there any mention of other parties building capacity? Possibly clinical sites opening, but that's their own trial sites. They mention "Seven U.S. clinical sites are now open for enrollment" - that's their own trial sites, not others building capacity. They mention "we continue to engage additional sites" - again their own. They mention "we formed a multiyear partnership with Memorial Sloan-Kettering Cancer Center" - that's a research collaboration, not building capacity. They mention "we plan to submit a preclinical briefing package to the FDA" - that's regulatory. They mention "we have now initiated clinical translation of our first off-the-shelf product candidate" - that's their own. No mention of customers or end markets building new capacity. The company is developing therapies, not supplying picks to a construction boom. The demand is from patients, but they are not describing others building new facilities or capacity that they supply into. Thus, answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| RDCM | RADCOM Ltd. | Q4 2023 | 2024-01-31 | A |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| IPGP | IPG Photonics Corporation | Q3 2021 | 2021-11-02 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
TEL · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by others, that's early or intensif...YES The transcript shows management framing the company's momentum chiefly through a wave of external capacity creation: EV production growth (40% in 2023, expected continued growth next year, with Asia as driver), renewable energy adoption (wind/solar), and AI/cloud applications. They describe others (OEMs, installers 3rd parties) building new productive capability—new EV platforms, renewable sites, AI clusters—while TE already supplies into it via content outperformance and early ramps. Current business is real (sequential order growth, $1.3B pipeline, $100M+ incremental AI revenue). The wave is early/intensifying 2024–2025 (3–4 year programs, more phases ahead, destocking normalizing). This is presented as the primary secular driver offsetting cyclical weakness, not just consumption or pricing. Other elements (destocking, FX) are secondary. Thus all three conditions are met in substance.
ATI · Q1 2018 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by other parties, like customers, t...YES The transcript shows management attributing HPMC momentum chiefly to the "ongoing production ramp of next-generation jet engines at all of our major engine OEM customers" and the "industry is currently in the early phases of a multi-year production expansion." This describes OEMs creating new productive capacity through rate ramps and build growth for next generation engines. Management confirms current business from this wave with "next-generation product sales reached 48% of total jet engine product sales" and "65% increase in next-generation product sales," plus "seventh consecutive quarter of year-over-year margin expansion.
RDCM · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building, equipping, or capacity-creation by other parties (custo...YES The transcript shows management framing 2024 momentum around operators’ ongoing 5G standalone network build-outs (new productive capacity being created by customers), with RADCOM already supplying assurance software to those projects and the wave described as still early and accelerating. All three conditions are met in Eyal Harari’s prepared remarks and Q&A.